SFS
CSCI

Sowell Financial Services’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Sowell Financial Services’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6
Closed -$1K – 2733
2019
Q4 		$1K Hold
6
– – ﹤0.01% 2451
2019
Q3 		$1K Buy
+6
New +$1.3K ﹤0.01% 2329

Other funds holding CSCI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sowell Financial Services's CSCI Position: Q1 2020 in Review

Sowell Financial Services sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q1 2020, closing a stake of 6 shares — an estimated $1K sold.

Sowell Financial Services first reported a position in CSCI in Q3 2019 and held it in 2 quarters. The position peaked at $1K in Q4 2019. 17 funds tracked by Wall St. Rank hold CSCI as of Q1 2020.

  • Sowell Financial Services reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Sowell Financial Services sold 6 COSCIENS Biopharma Inc. Common Stock shares in Q1 2020, an estimated $1K.
  • Sowell Financial Services first reported a position in COSCIENS Biopharma Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • Sowell Financial Services's COSCIENS Biopharma Inc. Common Stock position peaked at $1K in Q4 2019.
  • 17 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q1 2020.

Based on Sowell Financial Services's 13F filing for Q1 2020, filed 12 May 2020.